Efficacy and Safety of Camrelizumab in Real-World Prospective Study

NCT04793139 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Camrelizumab

Sponsor

Guangdong Association of Clinical Trials